_id
6915febebc934aba376b287b
Ticker
SRTOY
Name
Sartorius Stedim Biotech S.A
Exchange
PINK
Address
Zone Industrielle Les Paluds, Aubagne, France, 13781
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.sartorius.com
Description
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has collaboration with Bio Usawa Biotechnology, Ltd. focus on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Last Close
23.77
Volume
-
Current Price
24.848
Change
0
Last Updated
2026-01-07T12:22:13.118Z
Image
-
Ipo Date
-
Market Cap
23999995904
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
824644236
Cost Of Revenue
442061661
Gross Profit
382582574
Operating Expenses
219336436
Operating Income
163246138
Interest Expense
60063360
Pretax Income
102131084
Net Income
75020773
Eps
0.0077102678712881985
Dividends Per Share
2651948
Shares Outstanding
972964190
Income Tax Expense
26526036
EBITDA
254392872
Operating Margin
19.795947255005128
Total Other Income Expense Net
-61115053
Cash
350972500
Short Term Investments
-
Receivables
292810000
Inventories
849642500
Total Current Assets
1623497500
Property Plant Equipment
2319685000
Total Assets
9258412500
Payables
330292500
Short Term Debt
645662500
Long Term Debt
-
Total Liabilities
4473460000
Equity
4742535000
Bs_currency_symbol
-
Depreciation
92198427
Change In Working Capital
4041667
Cash From Operations
77367280
Capital Expenditures
157579390
Cash From Investing
-159647069
Cash From Financing
-368051645
Net Change In Cash
-469900805
Cf_currency_symbol
-
PE
74.2813
PB
50.979193644243004
ROE
1.5818707294727397
ROA
0.8102984501932703
FCF
-80212110
Fcf Percent
-0.09726874511252874
Piotroski FScore
4
Health Score
41
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
2
Economic Moat Investing Score
5.3
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
4
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
824644236
Quarters > 0 > income Statement > cost Of Revenue
442061661
Quarters > 0 > income Statement > gross Profit
382582574
Quarters > 0 > income Statement > operating Expenses
219336436
Quarters > 0 > income Statement > operating Income
163246138
Quarters > 0 > income Statement > interest Expense
60063360
Quarters > 0 > income Statement > pretax Income
102131084
Quarters > 0 > income Statement > net Income
75020773
Quarters > 0 > income Statement > eps
0.0077102678712881985
Quarters > 0 > income Statement > dividends Per Share
2651948
Quarters > 0 > income Statement > shares Outstanding
9729982700
Quarters > 0 > income Statement > income Tax Expense
26526036
Quarters > 0 > income Statement > EBITDA
254392872
Quarters > 0 > income Statement > operating Margin
19.795947255005128
Quarters > 0 > income Statement > total Other Income Expense Net
-61115053
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
350972500
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
292810000
Quarters > 0 > balance Sheet > inventories
849642500
Quarters > 0 > balance Sheet > total Current Assets
1623497500
Quarters > 0 > balance Sheet > property Plant Equipment
2319685000
Quarters > 0 > balance Sheet > total Assets
9258412500
Quarters > 0 > balance Sheet > payables
330292500
Quarters > 0 > balance Sheet > short Term Debt
645662500
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4473460000
Quarters > 0 > balance Sheet > equity
4742535000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
75020773
Quarters > 0 > cash Flow > depreciation
92198427
Quarters > 0 > cash Flow > change In Working Capital
4041667
Quarters > 0 > cash Flow > cash From Operations
77367280
Quarters > 0 > cash Flow > capital Expenditures
157579390
Quarters > 0 > cash Flow > cash From Investing
-159647069
Quarters > 0 > cash Flow > cash From Financing
-368051645
Quarters > 0 > cash Flow > net Change In Cash
-469900805
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.0077102678712881985
Quarters > 0 > ratios > PB
50.979193644243004
Quarters > 0 > ratios > ROE
1.5818707294727397
Quarters > 0 > ratios > ROA
0.8102984501932703
Quarters > 0 > ratios > FCF
-80212110
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
-0.09726874511252874
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
745000000
Quarters > 1 > income Statement > cost Of Revenue
400300000
Quarters > 1 > income Statement > gross Profit
344700000
Quarters > 1 > income Statement > operating Expenses
215700000
Quarters > 1 > income Statement > operating Income
129000000
Quarters > 1 > income Statement > interest Expense
30900000
Quarters > 1 > income Statement > pretax Income
92600000
Quarters > 1 > income Statement > net Income
68500000
Quarters > 1 > income Statement > eps
0.06900000022160584
Quarters > 1 > income Statement > dividends Per Share
67099999
Quarters > 1 > income Statement > shares Outstanding
992753620
Quarters > 1 > income Statement > income Tax Expense
24000000
Quarters > 1 > income Statement > EBITDA
201400000
Quarters > 1 > income Statement > operating Margin
17.315436241610737
Quarters > 1 > income Statement > total Other Income Expense Net
-36400000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
699300000
Quarters > 1 > balance Sheet > short Term Investments
45800000
Quarters > 1 > balance Sheet > receivables
263800000
Quarters > 1 > balance Sheet > inventories
693900000
Quarters > 1 > balance Sheet > total Current Assets
1807100000
Quarters > 1 > balance Sheet > property Plant Equipment
1954000000
Quarters > 1 > balance Sheet > total Assets
8312400000
Quarters > 1 > balance Sheet > payables
346900000
Quarters > 1 > balance Sheet > short Term Debt
133000000
Quarters > 1 > balance Sheet > long Term Debt
2684200000
Quarters > 1 > balance Sheet > total Liabilities
4273000000
Quarters > 1 > balance Sheet > equity
4003600000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
92600000
Quarters > 1 > cash Flow > depreciation
77900000
Quarters > 1 > cash Flow > change In Working Capital
-56900000
Quarters > 1 > cash Flow > cash From Operations
124900000
Quarters > 1 > cash Flow > capital Expenditures
75900000
Quarters > 1 > cash Flow > cash From Investing
-76900000
Quarters > 1 > cash Flow > cash From Financing
-53300000
Quarters > 1 > cash Flow > net Change In Cash
-8300000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
0.06900000022160584
Quarters > 1 > ratios > PB
6.161440191267858
Quarters > 1 > ratios > ROE
1.71096013587771
Quarters > 1 > ratios > ROA
0.82407006400077
Quarters > 1 > ratios > FCF
49000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.06577181208053691
Quarters > 1 > health Score
40
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
744600000
Quarters > 2 > income Statement > cost Of Revenue
388300000
Quarters > 2 > income Statement > gross Profit
356300000
Quarters > 2 > income Statement > operating Expenses
215000000
Quarters > 2 > income Statement > operating Income
141300000
Quarters > 2 > income Statement > interest Expense
63300000
Quarters > 2 > income Statement > pretax Income
115400000
Quarters > 2 > income Statement > net Income
85600000
Quarters > 2 > income Statement > eps
0.08800000024672898
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
972727270
Quarters > 2 > income Statement > income Tax Expense
30000000
Quarters > 2 > income Statement > EBITDA
256200000
Quarters > 2 > income Statement > operating Margin
18.97663174858985
Quarters > 2 > income Statement > total Other Income Expense Net
-25900000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
707600000
Quarters > 2 > balance Sheet > short Term Investments
19400000
Quarters > 2 > balance Sheet > receivables
320171280
Quarters > 2 > balance Sheet > inventories
683500000
Quarters > 2 > balance Sheet > total Current Assets
1780000000
Quarters > 2 > balance Sheet > property Plant Equipment
1926900000
Quarters > 2 > balance Sheet > total Assets
8303500000
Quarters > 2 > balance Sheet > payables
317000000
Quarters > 2 > balance Sheet > short Term Debt
90500000
Quarters > 2 > balance Sheet > long Term Debt
2683600000
Quarters > 2 > balance Sheet > total Liabilities
4295500000
Quarters > 2 > balance Sheet > equity
3972300000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
115400000
Quarters > 2 > cash Flow > depreciation
77400000
Quarters > 2 > cash Flow > change In Working Capital
-34700000
Quarters > 2 > cash Flow > cash From Operations
119800000
Quarters > 2 > cash Flow > capital Expenditures
65300000
Quarters > 2 > cash Flow > cash From Investing
-65300000
Quarters > 2 > cash Flow > cash From Financing
-25600000
Quarters > 2 > cash Flow > net Change In Cash
28700000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
0.08800000024672898
Quarters > 2 > ratios > PB
6.084718476691085
Quarters > 2 > ratios > ROE
2.154922840671651
Quarters > 2 > ratios > ROA
1.0308905883061361
Quarters > 2 > ratios > FCF
54500000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.07319366102605426
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
751300000
Quarters > 3 > income Statement > cost Of Revenue
435000000
Quarters > 3 > income Statement > gross Profit
316300000
Quarters > 3 > income Statement > operating Expenses
206700000
Quarters > 3 > income Statement > operating Income
109600000
Quarters > 3 > income Statement > interest Expense
11200000
Quarters > 3 > income Statement > pretax Income
40900000
Quarters > 3 > income Statement > net Income
45600000
Quarters > 3 > income Statement > eps
0.04711848944405308
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
967772960
Quarters > 3 > income Statement > income Tax Expense
-5400000
Quarters > 3 > income Statement > EBITDA
132700000
Quarters > 3 > income Statement > operating Margin
14.588047384533475
Quarters > 3 > income Statement > total Other Income Expense Net
-68700000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
678900000
Quarters > 3 > balance Sheet > short Term Investments
9900000
Quarters > 3 > balance Sheet > receivables
266800000
Quarters > 3 > balance Sheet > inventories
684900000
Quarters > 3 > balance Sheet > total Current Assets
1741000000
Quarters > 3 > balance Sheet > property Plant Equipment
1885100000
Quarters > 3 > balance Sheet > total Assets
8256400000
Quarters > 3 > balance Sheet > payables
310000000
Quarters > 3 > balance Sheet > short Term Debt
64600000
Quarters > 3 > balance Sheet > long Term Debt
2684400000
Quarters > 3 > balance Sheet > total Liabilities
4232600000
Quarters > 3 > balance Sheet > equity
3986600000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
40900000
Quarters > 3 > cash Flow > depreciation
80600000
Quarters > 3 > cash Flow > change In Working Capital
138500000
Quarters > 3 > cash Flow > cash From Operations
284900000
Quarters > 3 > cash Flow > capital Expenditures
80000000
Quarters > 3 > cash Flow > cash From Investing
-80200000
Quarters > 3 > cash Flow > cash From Financing
-11400000
Quarters > 3 > cash Flow > net Change In Cash
196300000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
0.04711848944405308
Quarters > 3 > ratios > PB
6.032012870636633
Quarters > 3 > ratios > ROE
1.1438318366527869
Quarters > 3 > ratios > ROA
0.5522988227314568
Quarters > 3 > ratios > FCF
204900000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.2727272727272727
Quarters > 3 > health Score
53
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2780000000
Annuals > 0 > income Statement > cost Of Revenue
1573300000
Annuals > 0 > income Statement > gross Profit
1206700000
Annuals > 0 > income Statement > operating Expenses
836100000
Annuals > 0 > income Statement > operating Income
370600000
Annuals > 0 > income Statement > interest Expense
158900000
Annuals > 0 > income Statement > pretax Income
219200000
Annuals > 0 > income Statement > net Income
175100000
Annuals > 0 > income Statement > eps
0.18093086626433538
Annuals > 0 > income Statement > dividends Per Share
67100000
Annuals > 0 > income Statement > shares Outstanding
967772960
Annuals > 0 > income Statement > income Tax Expense
40700000
Annuals > 0 > income Statement > EBITDA
670500000
Annuals > 0 > income Statement > operating Margin
13.330935251798563
Annuals > 0 > income Statement > total Other Income Expense Net
-151400000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
678900000
Annuals > 0 > balance Sheet > short Term Investments
9900000
Annuals > 0 > balance Sheet > receivables
266800000
Annuals > 0 > balance Sheet > inventories
684900000
Annuals > 0 > balance Sheet > total Current Assets
1741000000
Annuals > 0 > balance Sheet > property Plant Equipment
1885100000
Annuals > 0 > balance Sheet > total Assets
8256400000
Annuals > 0 > balance Sheet > payables
310000000
Annuals > 0 > balance Sheet > short Term Debt
64600000
Annuals > 0 > balance Sheet > long Term Debt
2684400000
Annuals > 0 > balance Sheet > total Liabilities
4232600000
Annuals > 0 > balance Sheet > equity
3986600000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
219200000
Annuals > 0 > cash Flow > depreciation
301700000
Annuals > 0 > cash Flow > change In Working Capital
251000000
Annuals > 0 > cash Flow > cash From Operations
815100000
Annuals > 0 > cash Flow > capital Expenditures
339800000
Annuals > 0 > cash Flow > cash From Investing
-340000000
Annuals > 0 > cash Flow > cash From Financing
84900000
Annuals > 0 > cash Flow > net Change In Cash
562300000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
0.18093086626433538
Annuals > 0 > ratios > PB
5.770321391461396
Annuals > 0 > ratios > ROE
4.392213916620679
Annuals > 0 > ratios > ROA
2.120779032023642
Annuals > 0 > ratios > FCF
475300000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.17097122302158274
Annuals > 0 > health Score
57
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2775500000
Annuals > 1 > income Statement > cost Of Revenue
1542000000
Annuals > 1 > income Statement > gross Profit
1233500000
Annuals > 1 > income Statement > operating Expenses
749000000
Annuals > 1 > income Statement > operating Income
484500000
Annuals > 1 > income Statement > interest Expense
121100000
Annuals > 1 > income Statement > pretax Income
401100000
Annuals > 1 > income Statement > net Income
309700000
Annuals > 1 > income Statement > eps
0.33604372435577856
Annuals > 1 > income Statement > dividends Per Share
132700000
Annuals > 1 > income Statement > shares Outstanding
921606260
Annuals > 1 > income Statement > income Tax Expense
89000000
Annuals > 1 > income Statement > EBITDA
755700000
Annuals > 1 > income Statement > operating Margin
17.456314177625654
Annuals > 1 > income Statement > total Other Income Expense Net
-83400000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
116600000
Annuals > 1 > balance Sheet > short Term Investments
9500000
Annuals > 1 > balance Sheet > receivables
293700000
Annuals > 1 > balance Sheet > inventories
882400000
Annuals > 1 > balance Sheet > total Current Assets
1415100000
Annuals > 1 > balance Sheet > property Plant Equipment
1633200000
Annuals > 1 > balance Sheet > total Assets
7739900000
Annuals > 1 > balance Sheet > payables
258500000
Annuals > 1 > balance Sheet > short Term Debt
79100000
Annuals > 1 > balance Sheet > long Term Debt
3509800000
Annuals > 1 > balance Sheet > total Liabilities
5066700000
Annuals > 1 > balance Sheet > equity
2638500000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
309700000
Annuals > 1 > cash Flow > depreciation
237600000
Annuals > 1 > cash Flow > change In Working Capital
190700000
Annuals > 1 > cash Flow > cash From Operations
629700000
Annuals > 1 > cash Flow > capital Expenditures
473600000
Annuals > 1 > cash Flow > cash From Investing
-2722700000
Annuals > 1 > cash Flow > cash From Financing
1986100000
Annuals > 1 > cash Flow > net Change In Cash
9500000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.33604372435577856
Annuals > 1 > ratios > PB
8.302664695925715
Annuals > 1 > ratios > ROE
11.737729770703051
Annuals > 1 > ratios > ROA
4.001343686610938
Annuals > 1 > ratios > FCF
156100000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.05624211853720051
Annuals > 1 > health Score
50
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3492700000
Annuals > 2 > income Statement > cost Of Revenue
1658200000
Annuals > 2 > income Statement > gross Profit
1834500000
Annuals > 2 > income Statement > operating Expenses
751700000
Annuals > 2 > income Statement > operating Income
995200000
Annuals > 2 > income Statement > interest Expense
41000000
Annuals > 2 > income Statement > pretax Income
1130400000
Annuals > 2 > income Statement > net Income
876100000
Annuals > 2 > income Statement > eps
0.9505973752032796
Annuals > 2 > income Statement > dividends Per Share
116100000
Annuals > 2 > income Statement > shares Outstanding
921630990
Annuals > 2 > income Statement > income Tax Expense
250500000
Annuals > 2 > income Statement > EBITDA
1330700000
Annuals > 2 > income Statement > operating Margin
28.49371546368139
Annuals > 2 > income Statement > total Other Income Expense Net
135200000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
107100000
Annuals > 2 > balance Sheet > short Term Investments
25900000
Annuals > 2 > balance Sheet > receivables
418600000
Annuals > 2 > balance Sheet > inventories
1024800000
Annuals > 2 > balance Sheet > total Current Assets
1671200000
Annuals > 2 > balance Sheet > property Plant Equipment
1292200000
Annuals > 2 > balance Sheet > total Assets
5065400000
Annuals > 2 > balance Sheet > payables
251500000
Annuals > 2 > balance Sheet > short Term Debt
24000000
Annuals > 2 > balance Sheet > long Term Debt
1020600000
Annuals > 2 > balance Sheet > total Liabilities
2551200000
Annuals > 2 > balance Sheet > equity
2449300000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
1130400000
Annuals > 2 > cash Flow > depreciation
181700000
Annuals > 2 > cash Flow > change In Working Capital
-351300000
Annuals > 2 > cash Flow > cash From Operations
612300000
Annuals > 2 > cash Flow > capital Expenditures
430600000
Annuals > 2 > cash Flow > cash From Investing
-957500000
Annuals > 2 > cash Flow > cash From Financing
220700000
Annuals > 2 > cash Flow > net Change In Cash
-116500000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
0.9505973752032796
Annuals > 2 > ratios > PB
8.94425698456702
Annuals > 2 > ratios > ROE
35.76940350304169
Annuals > 2 > ratios > ROA
17.295771311248863
Annuals > 2 > ratios > FCF
181700000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.052022790391387755
Annuals > 2 > health Score
61
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2886977000
Annuals > 3 > income Statement > cost Of Revenue
1333974000
Annuals > 3 > income Statement > gross Profit
1553003000
Annuals > 3 > income Statement > operating Expenses
670022000
Annuals > 3 > income Statement > operating Income
683301000
Annuals > 3 > income Statement > interest Expense
10398000
Annuals > 3 > income Statement > pretax Income
646720000
Annuals > 3 > income Statement > net Income
414400000
Annuals > 3 > income Statement > eps
0.44957068332216116
Annuals > 3 > income Statement > dividends Per Share
62683000
Annuals > 3 > income Statement > shares Outstanding
921768290
Annuals > 3 > income Statement > income Tax Expense
232411000
Annuals > 3 > income Statement > EBITDA
811959000
Annuals > 3 > income Statement > operating Margin
23.668390846203486
Annuals > 3 > income Statement > total Other Income Expense Net
-36601000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
223626000
Annuals > 3 > balance Sheet > short Term Investments
13721000
Annuals > 3 > balance Sheet > receivables
371716000
Annuals > 3 > balance Sheet > inventories
782954000
Annuals > 3 > balance Sheet > total Current Assets
1455629000
Annuals > 3 > balance Sheet > property Plant Equipment
928414000
Annuals > 3 > balance Sheet > total Assets
3951098000
Annuals > 3 > balance Sheet > payables
251300000
Annuals > 3 > balance Sheet > short Term Debt
40400000
Annuals > 3 > balance Sheet > long Term Debt
521072000
Annuals > 3 > balance Sheet > total Liabilities
2217871000
Annuals > 3 > balance Sheet > equity
1655866000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
646720000
Annuals > 3 > cash Flow > depreciation
141556000
Annuals > 3 > cash Flow > change In Working Capital
-145755000
Annuals > 3 > cash Flow > cash From Operations
695971000
Annuals > 3 > cash Flow > capital Expenditures
323987000
Annuals > 3 > cash Flow > cash From Investing
-465226000
Annuals > 3 > cash Flow > cash From Financing
-71711000
Annuals > 3 > cash Flow > net Change In Cash
163864000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
0.44957068332216116
Annuals > 3 > ratios > PB
13.232008056992534
Annuals > 3 > ratios > ROE
25.02617965463389
Annuals > 3 > ratios > ROA
10.488223779820192
Annuals > 3 > ratios > FCF
371984000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.12884896554423536
Annuals > 3 > health Score
69
Valuation > metrics > PE
74.2813
Valuation > metrics > PB
50.979193644243004
Valuation > final Score
1
Valuation > verdict
898.2% Overvalued
Profitability > metrics > ROE
1.5818707294727397
Profitability > metrics > ROA
4.620935541939547
Profitability > metrics > Net Margin
0.09097350072304392
Profitability > final Score
31
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9432634656359943
Risk > metrics > Interest Coverage
2.717898865464736
Risk > final Score
59
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.663496267758247
Liquidity > metrics > Quick Ratio
0.7929207801589213
Liquidity > final Score
81
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
29
Prev Profitabilities > 1
36
Prev Profitabilities > 2
19
Prev Risks > 0
47
Prev Risks > 1
39
Prev Risks > 2
69
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:37:35.775Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.0771
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0799
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0926
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.05
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-17
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.0288
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-07-18
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.0527
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-04-18
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.063
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-01-26
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.0464
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.0303
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.1572
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.1293
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.2066
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.2233
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.248
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-03-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.3287
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2021-12-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.0102
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-09-30
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.1889
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-06-30
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.1886
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-03-31
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.1496
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2020-12-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.1478
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-09-30
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.1287
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has collaboration with Bio Usawa Biotechnology, Ltd. focus on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACover Story: Stock picks for 2026 - Navigating opportunities and risks The Edge Malaysia
Read more →How the AI data center bubble story is playing out inside one booming energy stock CNBC
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Sartorius Stedim Biotech S.A
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.0771
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.